Medicare Enrolled
Dr. Robert Horowitz, MD
Medical Oncology · Ithaca, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Horowitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Horowitz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Horowitz
Dr. Robert Horowitz is a medical oncology specialist in Ithaca, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Horowitz performed 358 Medicare services across 253 unique beneficiaries.
Between the years covered by Open Payments, Dr. Horowitz received a total of $23,988 from 86 pharmaceutical and/or device companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Horowitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 358 Medicare services
$23,988 industry payments
Medicare Practice Summary
Medicare Utilization ↗358
Medicare services
Bottom 47% in NY for medical oncology
253
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~19 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
100 | $69 | $243 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
83 | $46 | $204 |
| New patient office visit, complex (60-74 min) | 34 | $124 | $600 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
31 | $59 | $266 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
29 | $91 | $382 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $133 | $746 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $97 | $369 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $25 | $169 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $109 | $293 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$23,988
Total received (2018-2024)
Avg $3,427/year across 7 years
Top 35% in NY for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
500
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,978 (54.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,659 (36.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,351 (9.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,095
2023
$1,599
2022
$1,491
2021
$2,687
2020
$1,977
2019
$1,614
2018
$12,524
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Halozyme Inc
$373
Eisai Inc.
$283
Novartis Pharmaceuticals Corporation
$206
Janssen Biotech, Inc.
$161
AstraZeneca Pharmaceuticals LP
$159
Tempus AI, Inc
$100
Lilly USA, LLC
$86
Alnylam Pharmaceuticals Inc.
$63
ABBVIE INC.
$59
PFIZER INC.
$57
ARRAY BIOPHARMA INC
$50
Ipsen Biopharmaceuticals, Inc
$47
Incyte Corporation
$47
JAZZ PHARMACEUTICALS INC.
$44
Amgen Inc.
$30
Kedrion Biopharma, Inc.
$28
Aveo Pharmaceuticals, Inc.
$25
Deciphera Pharmaceuticals Inc.
$24
Fresenius Kabi USA, LLC
$22
Mirati Therapeutics, Inc.
$21
Pharmacosmos Therapeutics Inc.
$21
GlaxoSmithKline, LLC.
$21
Coherus Biosciences Inc.
$20
SERVIER PHARMACEUTICALS LLC
$19
Daiichi Sankyo Inc.
$19
Genentech USA, Inc.
$18
Merck Sharp & Dohme LLC
$18
SpringWorks Therapeutics, Inc.
$17
Karyopharm Therapeutics Inc.
$17
Blueprint Medicines Corporation
$15
Adaptive Biotechnologies Corporation
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 41.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,939
Merck Sharp & Dohme Corporation
$4,552
Janssen Biotech, Inc.
$2,424
Gilead Sciences, Inc.
$1,143
Immunomedics, Inc.
$1,000
Daiichi Sankyo Inc.
$739
EMD Serono, Inc.
$619
Lilly USA, LLC
$616
Eisai Inc.
$578
BeiGene, Ltd.
$525
Genentech USA, Inc.
$451
Novartis Pharmaceuticals Corporation
$377
Halozyme Inc
$373
Amgen Inc.
$366
Exelixis Inc.
$319
E.R. Squibb & Sons, L.L.C.
$294
Novocure GmbH
$250
PFIZER INC.
$234
Celgene Corporation
$168
Adaptive Biotechnologies Corporation
$161
Pharmacyclics LLC, An AbbVie Company
$161
Clovis Oncology, Inc.
$148
Incyte Corporation
$142
Boston Scientific Corporation
$142
ARRAY BIOPHARMA INC
$139
INSYS Therapeutics Inc
$125
GENZYME CORPORATION
$124
Inari Medical, Inc.
$124
Janssen Scientific Affairs, LLC
$122
Sirtex Medical Inc
$116
Bayer HealthCare Pharmaceuticals Inc.
$106
Rigel Pharmaceuticals, Inc.
$102
Agios Pharmaceuticals, Inc.
$101
Seagen Inc.
$101
Tempus AI, Inc
$100
Astellas Pharma US Inc
$98
Novocure Inc.
$93
JAZZ PHARMACEUTICALS INC.
$91
TESARO, Inc.
$77
Puma Biotechnology, Inc.
$75
PharmaEssentia USA Corporation
$70
AbbVie, Inc.
$69
Janssen Pharmaceuticals, Inc
$67
GlaxoSmithKline, LLC.
$64
Medtronic Vascular, Inc.
$64
Alnylam Pharmaceuticals Inc.
$63
Karyopharm Therapeutics Inc.
$62
ABBVIE INC.
$59
SERVIER PHARMACEUTICALS LLC
$56
Deciphera Pharmaceuticals Inc.
$53
EISAI INC.
$52
AMAG Pharmaceuticals, Inc.
$51
Myriad Genetic Laboratories, Inc.
$48
Ipsen Biopharmaceuticals, Inc
$47
Mirati Therapeutics, Inc.
$42
Dova Pharmaceuticals
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Foundation Medicine, Inc.
$37
MorphoSys, US Inc.
$37
Alexion Pharmaceuticals, Inc.
$36
Array BioPharma Inc.
$36
Blueprint Medicines Corporation
$30
Takeda Pharmaceuticals U.S.A., Inc.
$28
Kedrion Biopharma, Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$26
Aveo Pharmaceuticals, Inc.
$25
Dendreon Pharmaceuticals LLC
$23
Verastem, Inc.
$23
Fresenius Kabi USA, LLC
$22
Pharmacosmos Therapeutics Inc.
$21
Servier Pharmaceuticals LLC
$20
Coherus Biosciences Inc.
$20
Acrotech Biopharma LLC
$19
Merck Sharp & Dohme LLC
$18
Taiho Oncology, Inc.
$18
Genentech, Inc.
$18
SpringWorks Therapeutics, Inc.
$17
Teva Pharmaceuticals USA, Inc.
$17
Apellis Pharmaceuticals, Inc.
$16
BeiGene USA, Inc.
$15
Aurobindo Pharma USA, Inc.
$14
CTI BioPharma Corp.
$14
Seattle Genetics, Inc.
$12
Epizyme, Inc.,
$12
Helsinn Therapeutics (U.S.), Inc.
$11
Innate Pharma, Inc
$11
Top 3 companies account for 49.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AYVAKIT · Abraxane · Albuked · Alecensa · Aliqopa · Asparlas · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · Copiktra · CoreValve Evolut · DARZALEX · Doptelet · ELIQUIS · ELREXFIO · EMEND · EPKINLY · ERLEADA · Empaveli · Enhertu · Erleada · FASLODEX · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FOUNDATIONONE · Fabhalta · Folotyn · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · IMLYGIC · INJECTAFER · Idhifa · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · Oncology · Onivyde · Optune · PADCEV · PRECISETUMOR · PROMACTA · PROVENGE · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · S · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SYNDROS · Stimufend · Stivarga · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tepmetko · Tibsovo · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · ZEJULA · ZEPZELCA · ZYKADIA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Medical oncologists within 10 mi
2
Per 100K population
1.9
County median income
$73,012
Nearest hospital
CAYUGA MEDICAL CENTER AT ITHACA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Horowitz is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Horowitz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Horowitz performed 100 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Horowitz receive payments from pharmaceutical companies?
Yes. Dr. Horowitz received a total of $23,988 from 86 companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Horowitz's costs compare to other medical oncologists in Ithaca?
Dr. Horowitz's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Horowitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Ithaca
Browse medical oncologists in Ithaca ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in NY
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in NY
Which NY medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology